Olympus Corporation of the Americas
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Olympus Corporation of the Americas sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
Olympus Corporation of the Americas: 14 sponsored US clinical trials, 3 recruiting.
Olympus Corporation of the Americas sponsors 14 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 8 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Emphysema, with 2 trials.
Top-decile sponsor footprint
Olympus Corporation of the Americas ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
14 total, page 1 of 1
Endoscopic Ultrasound Shear Wave Elastography Study
NCT06592820
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NCT04757116
STRIVE Post-Market Registry Study
NCT04302272
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
NCT04556201
Colorectal Polyp Clinical Decision Support Device Study
NCT04437615
The EUS ShearWave Elastography Liver Fibrosis Study
NCT04115046
ANET Electrosurgery Applicator Pilot Evaluation Study
NCT03400748
Spiration Valves Against Standard Therapy
NCT02382614
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
NCT02258230
Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
NCT02019030
Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function
NCT01812447
IBV Valve System for the Treatment of Prolonged Air Leak Under HDE H060002 - Post Approval Study
NCT01166516
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
NCT00475007
Pilot Study of the Spiration IBV™ System
NCT00145548
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Olympus Corporation of the Americas pipeline
3 recruiting of 14 indexed (21% open); 8 completed (57%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Emphysema (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Olympus Corporation of the Americas: open-pipeline peers nationwide
Peers matched on 14 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Olympus Corporation of the Americas sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Axsome Therapeutics · 21% recruiting · 28 trials
- GOG Foundation · 21% recruiting · 14 trials
- Kettering Health Network · 21% recruiting · 14 trials
- LifeBridge Health · 21% recruiting · 14 trials
Related
What to do with this Olympus Corporation of the Americas page
14 registered trials is a research-attention snapshot, not an endorsement of Olympus Corporation of the Americas or any single study.
- 3 of Olympus Corporation of the Americas's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Emphysema is the condition Olympus Corporation of the Americas studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Emphysema trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Olympus Corporation of the Americas pipeline card: 14 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.